Publications (128) Publications in which a researcher has participated

2023

  1. Evolución temporal de las variantes de SARS-CoV-2 circulantes en el área sanitaria de Cádiz

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia

  2. Simultaneous and divergent evolution of resistance to cephalosporin/β-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR Pseudomonas aeruginosa infections

    The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 5, pp. 1195-1200

  3. Detection of High Level of Co-Infection and the Emergence of Novel SARS CoV-2 Delta-Omicron and Omicron-Omicron Recombinants in the Epidemiological Surveillance of Andalusia

    International journal of molecular sciences, Vol. 24, Núm. 3

  4. Anticipatory Antifungal Treatment in Critically Ill Patients with SARS-CoV-2 Pneumonia

    Journal of Fungi, Vol. 9, Núm. 3

2022

  1. Protecting kidney transplant recipients against SARS-CoV-2 infection: A third dose of vaccine is necessary now

    American Journal of Transplantation

  2. Editorial: Translational research in hepatitis E, Vol II

    Frontiers in Microbiology

  3. Transmission of toxigenic Clostridiodes difficile between a pet dog with diarrhea and a 10-month-old infant

    Anaerobe, Vol. 74

  4. Serum microRNAs targeting ACE2 and RAB14 genes distinguish asymptomatic from critical COVID-19 patients

    Molecular Therapy - Nucleic Acids, Vol. 29, pp. 76-87

  5. Risk Factors and Predictive Score for Bacteremic Biliary Tract Infections Due to Enterococcus faecalis and Enterococcus faecium: a Multicenter Cohort Study from the PROBAC Project

    Microbiology spectrum, Vol. 10, Núm. 4, pp. e0005122

  6. Pseudomonas aeruginosa Community-Onset Bloodstream Infections: Characterization, Diagnostic Predictors, and Predictive Score Development—Results from the PRO-BAC Cohort

    Antibiotics, Vol. 11, Núm. 6

  7. In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida: A European Study

    Frontiers in Cellular and Infection Microbiology, Vol. 12

2021

  1. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020

    Nature, Vol. 595, Núm. 7869, pp. 707-712

  2. Revisiting the epidemiology of bloodstream infections and healthcare-associated episodes: results from a multicentre prospective cohort in Spain (PRO-BAC Study)

    International Journal of Antimicrobial Agents, Vol. 58, Núm. 1

  3. Predicting Pseudomonas aeruginosa susceptibility phenotypes from whole genome sequence resistome analysis

    Clinical Microbiology and Infection, Vol. 27, Núm. 11, pp. 1631-1637

  4. Molecular mechanisms driving the in vivo development of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDR Pseudomonas aeruginosa infections

    The Journal of antimicrobial chemotherapy, Vol. 76, Núm. 1, pp. 91-100

  5. Loss of smell and taste can accurately predict COVID-19 infection: A machine-learning approach

    Journal of Clinical Medicine, Vol. 10, Núm. 4, pp. 1-17

  6. Invasive fusariosis in nonneutropenic patients, Spain, 2000-2015

    Emerging Infectious Diseases, Vol. 27, Núm. 1, pp. 26-35

  7. Epidemiologic changes in bloodstream infections in Andalucía (Spain) during the last decade

    Clinical Microbiology and Infection, Vol. 27, Núm. 2, pp. 283.e9-283.e16

  8. Do specific antimicrobial stewardship interventions have an impact on carbapenem resistance in Gram-negative bacilli? A multicentre quasi-experimental ecological study: time-trend analysis and characterization of carbapenemases

    The Journal of antimicrobial chemotherapy, Vol. 76, Núm. 7, pp. 1928-1936

  9. Diagnostic pre-screening method based on N-gene dropout or delay to increase feasibility of SARS-CoV-2 VOC B.1.1.7 detection

    Diagnostic Microbiology and Infectious Disease, Vol. 101, Núm. 4